Topic: Emerging Targeted Therapies for Glioma
A Special Issue of Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)
Submission deadline: 10 Apr 2024
Guest Editor(s)
Special Issue Introduction
The Special Issue "Emerging Targeted Therapies for Glioma" delves into the forefront of innovative and targeted treatment strategies for gliomas. Gliomas, a type of brain tumor, present unique challenges in the realm of oncology due to their diverse molecular makeup and intricate interaction with the brain microenvironment.
This issue aims to explore the latest advancements in targeted therapies, including molecularly tailored treatments, immunotherapies, and precision medicine approaches specifically designed for glioma management. Contributions will encompass novel therapeutic interventions, significant breakthroughs in molecular profiling, and promising clinical trials that elucidate the evolving landscape of glioma treatment.
Authors contributing to this Special Issue illuminate diverse perspectives, providing insights into the development, mechanisms, and application of emerging targeted therapies for glioma. Embracing a multidisciplinary approach, these contributions integrate cutting-edge research, clinical perspectives, and translational insights aimed at improving patient outcomes and fostering a deeper understanding of glioma biology.
This issue aims to explore the latest advancements in targeted therapies, including molecularly tailored treatments, immunotherapies, and precision medicine approaches specifically designed for glioma management. Contributions will encompass novel therapeutic interventions, significant breakthroughs in molecular profiling, and promising clinical trials that elucidate the evolving landscape of glioma treatment.
Authors contributing to this Special Issue illuminate diverse perspectives, providing insights into the development, mechanisms, and application of emerging targeted therapies for glioma. Embracing a multidisciplinary approach, these contributions integrate cutting-edge research, clinical perspectives, and translational insights aimed at improving patient outcomes and fostering a deeper understanding of glioma biology.
Submission Deadline
10 Apr 2024
Submission Information
For Author Instructions, please refer to https://www.oaepublish.com/jcmt/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=jcmt&SpecialIssueId=jcmt20231121
Submission Deadline: 10 Apr 2024
Contacts: Frida Xu, Assistant Editor, frida-editor@jcmtjournal.com
